![Russia Pharmaceutical Industry](https://img.sputnikimages.com/images/vol5%2Fmedia%2Foriginal%2F0000%2F0817%2F05%2F000008170509_0%3A0%3A0%3A0_1400x1000_80_10_1_R3JpZ29yeSBTeXNvZXYgIzgxNzA1MDk%3D_116%3A95_sputnik-8170509-preview_83ac0588383090fe0cba5606e5911839.jpg)
![Russia Pharmaceutical Industry](https://img.sputnikimages.com/images/vol5%2Fmedia%2Foriginal%2F0000%2F0817%2F05%2F000008170509_0%3A0%3A0%3A0_1400x1000_80_10_1_R3JpZ29yeSBTeXNvZXYgIzgxNzA1MDk%3D_116%3A95_sputnik-8170509-preview_83ac0588383090fe0cba5606e5911839.jpg)
An employee works at the production site of medicines at the plant of the Amedart company in the Technopolis Moscow Special Economic Zone, in Moscow, Russia.
- Package: Russia Pharmaceutical Industry
- Categories: Economy, Business & Finance, Health
- Location: Moscow, Russia
- Event date: 20.04.2022
- Date published: 20.04.2022
- Author: Grigory Sysoev
- Credit: Sputnik
- Source: Sputnik
- Original: Digital
- Media: JPEG, 5060x3332px, 10.1Mb
- Job-ID: 8dcb54d56d1cd861